Unfortunately, as the years pass, wrinkles appear on the face, including the one commonly known as the frown line or anger ...
4,5,9 READY-4 is a phase III, multicenter, open-label study, designed to evaluate the safety of RelabotulinumtoxinA for the long-term treatment of moderate-to-severe frown lines and crow’s feet ...
Galderma today announced new phase III data from the READY-4 clinical trial, demonstrating the long-term safety of RelabotulinumtoxinA (Relfydess ™ ) for frown lines and crow’s feet after ...